AlloMap is a non-invasive blood test that helps physicians identify the risk of acute cellular rejection in heart transplant receipients.
Look for CareDx at the following 2017 conferences:
The International Society for Heart and Lung Transplantation
San Diego, CA
April 5-8, 2017
American Transplant Congress
April 29 - May 3, 2017